RSNA 2017 MRI Preview

Road to RSNA 2017: MRI Preview

By Wayne Forrest, contributing writer
November 1, 2017

MRI might be considered a mature modality, but creative and thoughtful researchers and clinicians are constantly exploring new avenues for the decades-old imaging technology.

Multiparametric MRI, hybrid multidimensional MRI, newly developed sequences for metal artifact reduction, and texture analysis are just a sampling of the advances designed to benefit patients for a wide variety of clinical indications.

In addition, functional MRI continues to play a prominent role in unlocking secrets of the brain -- what causes us to think and act the way we do, how we recover from concussions, and why dementia and Alzheimer's disease have become such devastating conditions.

At the same time, MRI has its share of controversy. Many practitioners rightly view the modality as an expensive imaging option. Here again is where resourcefulness leads to imaginative approaches. This year's RSNA 2017 agenda offers strategies to shorten scan times to reduce costs and yield diagnostic results, while appropriate use criteria provide a direct and informed path to improved outcomes.

The safety of gadolinium-based contrast agents (GBCAs) again will take center stage at RSNA 2017. The discussion continues regarding how gadolinium retention occurs in many areas of the body and to what extent that accumulation may or may not affect patients' long-term health.

Could ferumoxytol-enhanced MRI be the solution? How safe are MRI scans in patients with implantable cardiac electronic devices? The answers to those questions and more are available in the summaries of MRI-related scientific presentations and open forums below.

To view the RSNA's complete listing of abstracts for the 2017 scientific and educational program, click here.

Scientific and Educational Presentations
Easy-to-use DWI quality assurance may soon be the norm
Sunday, November 26 | 10:55 a.m.-11:05 a.m. | SSA22-02 | Room S405AB
"Simpler and more feasible" is how researchers from Purdue University describe their new diffusion-weighted MR imaging (DWI-MRI) quality assurance method based on an American College of Radiology phantom.
5-minute MRI protocol can be effective for knee scans
Sunday, November 26 | 11:25 a.m.-11:35 a.m. | SSA14-05 | Room S406A
How does the diagnostic performance of a five-minute knee MRI protocol compare with that of a standard knee MRI protocol? Dr. Erin Alaia, a musculoskeletal radiologist at NYU Langone Health in New York City, will share the answer in this presentation.
NIST's mission to make a better MRI phantom
Sunday, November 26 | 11:25 a.m.-11:35 a.m. | SSA22-05 | Room S405AB
In this session, researchers from the U.S. National Institute of Standards and Technology (NIST) will detail their efforts to increase the accuracy of MRI phantoms by developing primary calibration structures that follow International System of Units guidelines.
MRI adds to squamous cell carcinoma evaluation
Sunday, November 26 | 11:25 a.m.-11:35 a.m. | SSA19-05 | Room N230B
In a presentation on Sunday, U.K. researchers plan to report encouraging results on the use of MRI texture analysis to detect extracapsular nodal spread related to oral cavity squamous cell carcinoma.
Ferumoxytol-enhanced MRI could benefit glioma patients
Sunday, November 26 | 11:35 a.m.-11:45 a.m. | SSA17-06 | Room N228
Researchers from Stanford University plan to provide additional evidence on the potential for ferumoxytol-enhanced MRI to detect and quantify macrophages in high-grade gliomas.
Multiparametric MRI's role in assessing renal dysfunction
Sunday, November 26 | 12:05 p.m.-12:15 p.m. | SSA10-09 | Room E351
In this study, researchers set out to determine the test-retest repeatability of multiparametric MRI parameters to differentiate between renal dysfunction and normal physiological variation and measurement noise.
MRI can save millions by monitoring MS treatment
Monday, November 27 | 10:30 a.m.-10:40 a.m. | SSC12-01 | Room N226
How much savings could be realized by using MRI to assess lesions and brain atrophy in patients with multiple sclerosis? The total could reach $400 million, according to this study by researchers from Belgian imaging biomarker firm Icometrix.
fMRI finds what makes a good business manager
Monday, November 27 | 10:40 a.m.-10:50 a.m. | SSC11-02 | Room N229
Do savvy business managers have an advantage over their peers? Researchers from several countries explored this question through functional MRI (fMRI) brain scans, finding that increased activation in one particular region of the brain may help prevent costly mistakes.
fMRI advances research of neurological conditions
Monday, November 27 | 11:00 a.m.-11:10 a.m. | SSC11-04 | Room N229
By using functional MRI (fMRI) to see how healthy people make decisions, researchers are hoping to provide baseline activity biomarkers to better understand the differences in people with neurological conditions such as schizophrenia and dementia.
Breast MRI neural network predicts treatment response
Monday, November 27 | 11:50 a.m.-12:00 p.m. | RC215-17 | Arie Crown Theater
In this session, researchers will discuss how neural networks based on a breast MRI tumor dataset can help clinicians predict patient response to neoadjuvant chemotherapy.
Resting-state fMRI circumvents brain lesion dilemma
Monday, November 27 | 11:50 a.m.-12:00 p.m. | SSC11-09 | Room N229
Can functional MRI (fMRI) still be effective when brain lesions create morphological distortion and patients are unable to perform tasks during scans? Researchers from NYU Langone Medical Center have found that resting-state fMRI can be used as an option to identify sensorimotor networks.
Appropriate use criteria meet MRI lumbar scans
Monday, November 27 | 3:10 p.m.-3:20 p.m. | SSE18-02 | Room N229
Whether an MRI scan of the lumbar spine is appropriate for cases of back pain greatly depends on information provided by the requesting clinician at the time of order entry, according to this study from researchers at multiple U.S. imaging centers.
Ultrahigh-field MRI views potential ALS biomarkers
Monday, November 27 | 3:30 p.m.-3:40 p.m. | SSE18-04 | Room N229
Using ultrahigh-field MRI to view microstructural changes in postmortem tissue could advance research in amyotrophic lateral sclerosis (ALS), according to this study from the University of Chicago.
Breast MRI performs well across many risk factors
Tuesday, November 28 | 8:50 a.m.-9:00 a.m. | RC315-02 | Arie Crown Theater
Screening breast MRI is an effective tool for women who carry the BRCA mutation and also for those with a history of breast cancer and/or high-risk lesions, according to research being presented Tuesday morning.
ACR's R-SCAN helps cut inappropriate lumbar spine MRI scans
Tuesday, November 28 | 10:50 a.m.-11:00 a.m. | SSG06-03 | Room S104B
In this session, researchers will share how they used the American College of Radiology (ACR) Radiology Support, Communication, and Alignment Network (R-SCAN) to address inappropriate utilization of lumbar spine MRI in patients with lower back pain.
Multiparametric MRI offers options for prostate cancer
Tuesday, November 28 | 11:10 a.m.-11:20 a.m. | SSG05-05 | Room S102CD
Multiparametric MRI can successfully detect prostate cancer with or without contrast enhancement, according to this presentation by researchers from Brazil.
Deep learning with breast MRI boosts lesion detection
Tuesday, November 28 | 11:20 a.m.-11:30 a.m. | RC315-14 | Arie Crown Theater
A deep-learning method using multiparametric breast MRI improves automated detection and characterization of breast lesions, according to research being presented at this Tuesday morning session.
How safe are GBCAs for cardiac MRI scans?
Tuesday, November 28 | 12:15 p.m.-12:45 p.m. | CA226-SD-TUA3 | Lakeside, CA Community, Station 3
In this presentation, European researchers offer evidence that gadolinium-based contrast agents (GBCAs) are safe for use in cardiac MRI applications, at least with respect to acute events.
3T MRI scans won't make waves for fetuses
Tuesday, November 28 | 3:20 p.m.-3:30 p.m. | SSJ10-03 | Room E351
Smooth sailing awaits fetuses who are exposed to 3-tesla MRI scans. That conclusion comes from U.S. Navy clinicians who found no subsequent evidence of adverse fetal growth or neonatal hearing impairment.
Contrast agent education, controversies take center stage
Tuesday, November 28 | 4:30 p.m.-6:00 p.m. | RC407 | Room S406B
In this 90-minute forum, experts in the area of contrast agents will discuss gadolinium retention, allergic reactions, and other risks and challenges that patients and clinicians face on a daily basis.
Patients with ICEDs can have 'controlled' MRI scans
Wednesday, November 29 | 10:30 a.m.-10:40 a.m. | SSK04-01 | Room S504AB
In this presentation, Italian researchers will offer good news for patients with implantable cardiac electronic devices (ICEDs) who are scheduled to undergo MRI scans.
Hybrid multidimensional MRI takes on prostate cancer
Wednesday, November 29 | 10:50 a.m.-11:00 a.m. | SSK09-03 | Room E450B
Researchers from the University of Chicago are looking to bring hybrid multidimensional MRI to the forefront of prostate cancer detection and assessment.
MRI follow-up a must after prostate cancer ablation
Wednesday, November 29 | 11:00 a.m.-11:10 a.m. | SSK09-04 | Room E450B
MRI's ability to detail changes in the prostate after focal ablation can help clinicians distinguish between normal findings and the possible recurrence of cancer, according to the findings of a study to be presented on Wednesday.
How can cardiac MRI predict ablation therapy outcomes?
Wednesday, November 29 | 11:20 a.m.-11:30 a.m. | SSK04-06 | Room S504AB
Adding late gadolinium enhancement and T1 mapping in preprocedural cardiac MRI scans might help predict how atrial fibrillation patients will respond to ablation therapy, German researchers have found.
MRI could be replaced for some muscle injuries
Wednesday, November 29 | 3:40 p.m.-3:50 p.m. | SSM14-05 | Room E353C
MRI has been the modality of choice to analyze and characterize intramuscular lesions, but the findings of this study by German researchers suggest that contrast-enhanced ultrasound may be a better option for assessing muscle injuries.
Gadolinium study looks at cerebrospinal fluid
Wednesday, November 29 | 3:50 p.m.-4:00 p.m. | SSM16-06 | Room N226
Research into gadolinium retention continues to expand: In this study, researchers tracked the accumulation of gadolinium-based contrast agents in cerebrospinal fluid.
Novel algorithm targets atypical uterine masses
Thursday, November 30 | 10:50 a.m.-11:00 a.m. | SSQ10-03 | Room E353B
In this session, researchers from France will unveil their newly created diagnostic flow chart algorithm designed to characterize atypical uterine masses seen on MRI.
MRI gets 'smart' with tumor prostheses assessment
Thursday, November 30 | 11:20 a.m.-11:30 a.m. | SSQ13-06 | Room E451A
Researchers from Johns Hopkins University have developed a novel MRI technique that achieves high diagnostic accuracy in the surveillance of patients following resection and reconstruction with a tumor prosthesis.
Texture analysis helps differentiate breast abnormalities
Thursday, November 30 | 11:50 a.m.-12:00 p.m. | SSQ01-09 | Room E450A
Japanese researchers plan to extol the diagnostic performance of texture analysis with dynamic contrast-enhanced breast MRI for nonmass enhancement and the differentiation of malignant and benign lesions.
Breast MRI neural networks predict recurrence scores
Friday, December 1 | 11:20 a.m.-11:30 a.m. | SST01-06 | Room E450B
Researchers in New York have found that deep-learning networks can be trained with breast MRI data to predict Oncotype DX recurrence scores.